title: Discovery of a series of aromatic lactones as ALDH1/2-directed inhibitors.
abstract: In humans, the aldehyde dehydrogenase superfamily consists of 19 isoenzymes which mostly catalyze the NAD(P)(+)-dependent oxidation of aldehydes. Many of these isoenzymes have overlapping substrate specificities and therefore their potential physiological functions may overlap. Thus the development of new isoenzyme-selective probes would be able to better delineate the function of a single isoenzyme and its individual contribution to the metabolism of a particular substrate. This specific study was designed to find a novel modulator of ALDH2, a mitochondrial ALDH isoenzyme most well-known for its role in acetaldehyde oxidation. 53 compounds were initially identified to modulate the activity of ALDH2 by a high-throughput esterase screen from a library of 63,000 compounds. Of these initial 53 compounds, 12 were found to also modulate the oxidation of propionaldehyde by ALDH2. Single concentration measurements at 10μM compound were performed using ALDH1A1, ALDH1A2, ALDH1A3, ALDH2, ALDH1B1, ALDH3A1, ALDH4A1, and/or ALDH5A1 to determine the selectivity of these 12 compounds toward ALDH2. Four of the twelve compounds shared an aromatic lactone structure and were found to be potent inhibitors of the ALDH1/2 isoenzymes, but have no inhibitory effect on ALDH3A1, ALDH4A1 or ALDH5A1. Two of the aromatic lactones show selectivity within the ALDH1/2 class, and one appears to be selective for ALDH2 compared to all other isoenzymes tested.
authors: Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202-5122, United States.
authors: Cameron D
authors: CD
authors: Buchman
authors: Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202-5122, United States.
authors: Krishna K
authors: KK
authors: Mahalingan
authors: Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202-5122, United States. Electronic address: thurley@iu.edu.
authors: Thomas D
authors: TD
authors: Hurley
mesh_terms: D000079:Acetaldehyde / Q000378:metabolism; D000444:Aldehyde Dehydrogenase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D000080924:Aldehyde Dehydrogenase 1 Family; D000071396:Aldehyde Dehydrogenase, Mitochondrial; D000447:Aldehydes / Q000378:metabolism; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors* / Q000378:metabolism; D007783:Lactones / Q000378:metabolism*; D008928:Mitochondria / Q000378:metabolism; D009249:NADP / Q000378:metabolism; D010084:Oxidation-Reduction; D050697:Retinal Dehydrogenase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D013379:Substrate Specificity
chemical_list: D000447:Aldehydes; D007527:Isoenzymes; D007783:Lactones; D009249:NADP; C005556:propionaldehyde; D000080924:Aldehyde Dehydrogenase 1 Family; C096127:ALDH2 protein, human; D000444:Aldehyde Dehydrogenase; D000071396:Aldehyde Dehydrogenase, Mitochondrial; C510223:ALDH1A1 protein, human; D050697:Retinal Dehydrogenase; D000079:Acetaldehyde
keywords: Aldehyde dehydrogenase; High-throughput screening; Inhibition
references: Biochem Biophys Res Commun. 2011 Feb 11;405(2):173-9
references: 21216231
references: Drug Metab Dispos. 2010 Oct;38(10):1679-87
references: 20616185
references: J Med Chem. 2014 Feb 13;57(3):714-22
references: 24444054
references: Chembiochem. 2014 Mar 21;15(5):701-12
references: 24677340
references: Pharmacogenetics. 1999 Aug;9(4):421-34
references: 10780262
references: Eur J Biochem. 2000 Jul;267(14):4315-24
references: 10880953
references: Pharmacology. 2000 Sep;61(3):192-8
references: 10971205
references: Chem Biol Interact. 2000 Dec 1;129(1-2):1-19
references: 11154732
references: Biochemistry. 2002 Jun 4;41(22):7156-68
references: 12033950
references: Chem Res Toxicol. 2003 Feb;16(2):145-52
references: 12588185
references: Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14036-41
references: 14623956
references: Biochem J. 2003 Dec 15;376(Pt 3):615-23
references: 12943535
references: Drug Metab Rev. 2004 May;36(2):279-99
references: 15237855
references: Cancer Res. 1984 Nov;44(11):5156-60
references: 6488175
references: J Biol Chem. 1986 Feb 15;261(5):2154-63
references: 3944130
references: Alcohol Clin Exp Res. 1989 Dec;13(6):755-61
references: 2690658
references: J Biol Chem. 1992 Sep 25;267(27):19724-9
references: 1527093
references: Biochem Pharmacol. 1993 Jun 22;45(12):2487-505
references: 8328987
references: J Biol Chem. 1994 May 13;269(19):13854-60
references: 7910607
references: Alcohol Alcohol Suppl. 1993;1B:15-9
references: 8003124
references: Biochem Biophys Res Commun. 1995 Jun 6;211(1):144-51
references: 7779080
references: Biochemistry. 1996 Apr 9;35(14):4445-56
references: 8605194
references: Biochemistry. 1996 Apr 9;35(14):4457-67
references: 8605195
references: J Biol Chem. 1996 Jul 5;271(27):16288-93
references: 8663198
references: Hum Mol Genet. 1998 Sep;7(9):1411-5
references: 9700195
references: Hum Mutat. 2005 Jul;26(1):1-10
references: 15931689
references: Nat Genet. 1999 Apr;21(4):444-8
references: 10192400
references: Mutat Res. 1998 Dec 3;420(1-3):99-107
references: 9838066
references: Crit Rev Toxicol. 2005 Aug;35(7):609-62
references: 16417045
references: Chem Res Toxicol. 2006 Feb;19(2):195-208
references: 16485895
references: Cancer Chemother Pharmacol. 2007 Jan;59(1):127-36
references: 16614850
references: Pharmacol Rev. 2007 Jun;59(2):125-50
references: 17379813
references: Expert Opin Drug Metab Toxicol. 2008 Jun;4(6):697-720
references: 18611112
references: Br J Pharmacol. 2008 Sep;155(2):170-84
references: 18574453
references: Chem Biol Interact. 2011 May 30;191(1-3):153-8
references: 21349255